Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07092774 · ClinicalTrials.gov registry record
Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)
A clinical trial of Paroxysmal Atrial Fibrillation (PAF), sponsored by Heart Rhythm Clinical and Research Solutions.
- Active
- Registry status
- 344
- Enrollment target
- 12
- Study locations
NCT07092774: Active study of Paroxysmal Atrial Fibrillation (PAF), sponsored by Heart Rhythm Clinical and Research Solutions.
NCT07092774 is a study of Paroxysmal Atrial Fibrillation (PAF) that is active but no longer recruiting, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 344 participants. The trial reports 12 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07092774, a study of Paroxysmal Atrial Fibrillation (PAF), is active but no longer recruiting, sponsored by Heart Rhythm Clinical and Research Solutions.
- ACTIVE NOT RECRUITING
- Registry status
- 344 participants
- Enrollment target
- 12
- Study locations
Study Summary
To generate real-world evidence from the parent study, REAL AF registry, on the use of Thermocool SmartTouch SF (STSF) catheter in ablation for the treatment of paroxysmal atrial fibrillation (PAF).
Primary Outcome
Freedom from atrial arrhythmia recurrence
Conditions Studied
Interventions
- DEVICE Ablation
Study Locations (12)
Florida
- Ascension St. Vincent's - Jacksonville
- Sarasota Memorial Hospital - Sarasota
Pennsylvania
- University of Pennsylvania, Penn Presbyterian Medical Center - Philadelphia
- Allegheny Health Network - Pittsburgh
Alabama
- Arrhythmia Institute at Grandview - Birmingham
California
- Community Memorial Hospital - Ventura
Illinois
- Northshore University Health System - Evanston
Indiana
- Ascension St. Vincent's Hospital - Indianapolis
Michigan
- Michigan Heart - Ypsilanti
Ohio
- Mount Carmel Columbus Cardiology Consultants - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 344 participants |
| Start Date | 2024-04-01 |
| Est. Completion | 2025-12 |
What the registry record for NCT07092774 still lists
NCT07092774 is an observational study that tracks outcomes without assigning an intervention. The registered 344 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation (PAF) appearing as the primary indexed condition, and to 1 intervention - of which Ablation is the first listed.
NCT07092774 lists 12 locations in 10 states (Florida, Pennsylvania, Alabama).
Frequently Asked Questions
What is clinical trial NCT07092774 about?
NCT07092774 is a clinical study titled "Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)". To generate real-world evidence from the parent study, REAL AF registry, on the use of Thermocool SmartTouch SF (STSF) catheter in ablation for the treatment of paroxysmal atrial fibrillation (PAF).
What is the current status of trial NCT07092774?
This trial is currently active not recruiting. The enrollment target is 344 participants. The study started on 2024-04-01. Estimated completion is 2025-12.
What conditions does trial NCT07092774 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation (PAF).
What interventions are being tested in trial NCT07092774?
The interventions under investigation include: Ablation (DEVICE).
Who is sponsoring clinical trial NCT07092774?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07092774 being conducted?
This trial has 12 study locations across Alabama, California, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation (PAF)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06733363 · 344 participants · Phase 2
A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer
- NCT07179380 · 344 participants · Phase 3
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- NCT07304024 · 344 participants · Phase 1
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
- NCT03972657 · 345 participants · Phase 1
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI